Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients

Bone Marrow Transplantation

Volumn 27, Issue 1, 2001, Pages 79-84

  Parkkali, T ^a   Kayhty H ^b   Lehtonen, H ^b   Ruutu, T ^a   Volin, L ^a   Eskola, J ^b   Ruutu, P ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

BMT recipients; Meningococcal antibodies; Vaccination response

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; MENINGOCOCCUS VACCINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BACTERIAL MENINGITIS; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOGENICITY; METHODOLOGY; MILITARY SERVICE; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SEROTYPE; SIBLING; TIME; TRAVEL; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035144542     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702742     Document Type: Article

References (42)

1. Control and prevention of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales
3. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6
4. The epidemiology of meningococcal disease in England and Wales, 1996 and 1997
5. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants
6. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: Prospects for routine immunization of infants and children
7. 135) meningococcal vaccines in infants and small children: A clinical study comparing immunogenicity of O-Acetyl-Negative and O-Acetyl-Positive group C polysaccharides
8. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children
9. Immunologic reconstitution after human marrow grafting
10. The kinetics of immune reconstitution after human marrow transplantation
11. Immune recovery after bone marrow transplantation
12. Reconstitution of B cell immunity following bone marrow transplantation
13. Pneumococcal vaccination of recipients of bone marrow transplants
14. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine
15. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients
16. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation
17. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: The influence of graft versus host reaction
18. Polysaccharide conjugate vaccine responses in bone marrow transplant patients
19. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation
20. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT
21. Invasive pneumococcal infection following PBSCT and BMT - An EBMT survey
22. Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
23. Role of postremission chemotherapy in recipients of HLA-identical sibling transplants for acute myelogenous leukemia in first remission
24. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: Study
25. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation
26. Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine
27. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccines and carriers
28. Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992
29. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age
30. Immunisations after bone marrow transplantation: Results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation
31. Immunization of transplant recipients
32. Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation
33. Recovery of anti-body production in human allogeneic marrow graft recipients: Influence of time post transplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment
34. Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and children
35. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children: A randomized controlled trial
36. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: A randomized controlled trial
37. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory
38. Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide
39. Duration of anti-body response after meningococcal polysaccharide vaccination in US Air Force personnel
40. Meningococcal disease prevention and control strategies for practice-based physicians
41. Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease